Biobank Quality Management in the BBMRI.be Network.
BBMRI.be
ISO 20387
QMS
audit
biobank
quality
survey
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
04
2019
accepted:
07
06
2019
entrez:
12
7
2019
pubmed:
12
7
2019
medline:
12
7
2019
Statut:
epublish
Résumé
From as early as 2005, different guidelines and quality standards covering biobank activities and sample handling methods have been developed to improve and guarantee the reproducibility of biomarker research. Ten years on, the BBMRI.be Quality working group wanted to gauge the current situation of these aspects in the biobanks of the BBMRI.be network. To this end, two online surveys were launched (fall 2017 and fall 2018) to the biobank quality managers in the BBMRI.be network to determine the status and setup of their current quality management system (QMS) and how their QMS and related practices have evolved over a 14 month time period. All biobanks addressed by the two surveys provided a complete response (12 and 13, respectively). A QMS was implemented in 85% of biobanks, with 4 standards emerging as primary basis. Supplementary guidelines were used, with a strong preference for the ISBER best practices for biobanks. The Standard Preanalytical Code-an indicator of the preanalytical lifecycle of a biospecimen impacting the downstream analysis results-was already implemented in 50% of the biobanks while the other half intends future implementation. To assess and maintain the quality of their QMS, 62% of biobanks used self-assessment tools and 71% participated in proficiency testing schemes. The majority of biobanks had implemented procedures for general and biobank specific activities. However, policies regarding the business and sustainability aspect of biobank were only implemented in a limited number of biobanks. A clear desire for a peer-review audit was expressed by 69% of biobanks, with over half of them intending to implement the recently published biobank standard ISO20387. Overall, the biobanks of the BBMRI.be network have actively implemented a solid quality approach in their practices. The implementation of ISO 20387 may bring further professionalization of activities. Based on the needs expressed in this survey, the Quality working group will be setting up an audit program for the BBMRI.be biobanks, to enhance, harmonize and streamline their activities. On the whole, the biobanks in the BBMRI.be network are able to substantially contribute to translational research, as a primary facilitator guaranteeing high quality standards and reproducibility.
Identifiants
pubmed: 31294024
doi: 10.3389/fmed.2019.00141
pmc: PMC6606712
doi:
Types de publication
Journal Article
Langues
eng
Pagination
141Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1004-11
pubmed: 20332280
J Proteome Res. 2011 Aug 5;10(8):3429-38
pubmed: 21574648
Hum Genet. 2011 Sep;130(3):357-68
pubmed: 21814798
Nature. 2012 Mar 28;483(7391):531-3
pubmed: 22460880
Clin Biochem. 2014 Mar;47(4-5):300-8
pubmed: 24406300
Biopreserv Biobank. 2013 Dec;11(6):387-96
pubmed: 24835369
Biopreserv Biobank. 2009 Sep;7(3):143-50
pubmed: 24835880
Biopreserv Biobank. 2011 Dec;9(4):415-7
pubmed: 24836637
Biopreserv Biobank. 2011 Jun;9(2):157-63
pubmed: 24846261
Biopreserv Biobank. 2012 Aug;10(4):343-8
pubmed: 24849882
PLoS Biol. 2015 Jun 09;13(6):e1002165
pubmed: 26057340
Biopreserv Biobank. 2016 Aug;14(4):298-306
pubmed: 26977825
Biopreserv Biobank. 2016 Oct;14(5):429-439
pubmed: 27195612
Biopreserv Biobank. 2017 Feb;15(1):9-16
pubmed: 27740852
Biopreserv Biobank. 2017 Oct;15(5):438-450
pubmed: 28922617
Biopreserv Biobank. 2018 Feb;16(1):7-8
pubmed: 29359960
Biopreserv Biobank. 2018 Jan 29;:null
pubmed: 29377712
Biopreserv Biobank. 2018 Feb;16(1):3-6
pubmed: 29393664
Biopreserv Biobank. 2018 Feb;16(1):23-27
pubmed: 29394084
Biopreserv Biobank. 2018 Feb;16(1):16-22
pubmed: 29394087
Biopreserv Biobank. 2019;17(1):71-75
pubmed: 30412417
N Biotechnol. 2019 Sep 25;52:121-125
pubmed: 31102798